CD44 and colorectal cancer: Phenethyl isothiocyanate showed promising results on colorectal cancer stem cells (in vitro and in vivo) by decreasing the expression of stemness markers (Nanog, Oct4, Sox2, ALDH1, CD44, EpCAM), inhibiting EMT, and down-regulating ERK and phosphor-Smad2/3.